During the past decade, Pennington Cancer Center at Baton Rouge General conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pennington Cancer Center at Baton Rouge General" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "Radiation Therapy Oncology Group" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pennington Cancer Center at Baton Rouge General" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Pennington Cancer Center at Baton Rouge General" are "Breast Cancer" (6 trials), "Prostate Cancer" (4 trials), "Leukemia" (3 trials), "Head and Neck Cancer" (2 trials) and "Kidney Cancer" (2 trials). Many other conditions were trialed in "Pennington Cancer Center at Baton Rouge General" in a lesser frequency.

Most popular intervention types in "Pennington Cancer Center at Baton Rouge General" are "Drug" (21 trials), "Radiation" (8 trials), "Biological" (6 trials), "Other" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (4 trials), "radiation therapy" (4 trials), "cyclophosphamide" (3 trials), "fluorouracil" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pennington Cancer Center at Baton Rouge General" are 17 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Pennington Cancer Center at Baton Rouge General". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Pennington Cancer Center at Baton Rouge General, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pennington Cancer Center at Baton Rouge General, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".